高度門脈腫瘍栓（Vp3/4）を伴う進行肝細胞癌に対してのソラフェニブ投与の治療成績
スポンサーリンク
概要
- 論文の詳細を見る
We investigated efficacy of sorafenib therapy for advanced hepatocellular carcinoma (HCC) with Vp3/4 portal vein tumor thrombosis. According to modified RECIST, the therapeutic responses in Vp0/2 group (n=30) were 8 PR, 14 SD and 8 PD cases, and while those in Vp3/4 group (n=11) were 5 PR, 2 SD and 4 PD cases. The response rates and cumulative progression rates were not significantly different between two groups. The cumulative survival rates in Vp3/4 group were significantly lower than those in Vp0/2 group. The deteriorations of Child-Pugh scores in Vp3/4 group were significantly higher than those in Vp0/2 group. The possibility of the deterioration of liver function should be kept in mind during sorafenib therapy for advanced HCC with Vp3/4.
論文 | ランダム
- The Quality of Extra Strong Flour Used in Bread Production with Frozen Dough
- The Bread-Making Quality of a Domestic Flour Blended with an Extra Strong Flour, and Staling of the Bread Made from the Blended Flour
- 多重手術の問題点(黄斑手術と白内障手術)
- New trends in surgical treatment for portal hypertension
- The Cytotoxic Effects of Bile Acids in Crude Bile on Human Pancreatic Cancer Cell Lines